IMMUTEP LIMITED
Who is IMMUTEP LIMITED?
Immutep is a late-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesses LAG-3’s abi...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
LEVEL 33, AUSTRALIA SQUARE 264 GEORGE STREET; SYDNEY, NSW 2000, AU
Employees by Department
- Operations (1)
- The Rest (7)
- Total (8)
Key Decision Makers
Russell J Howard
Chairman of the Board
David Fang Fcpa
Finance Director and Assistant Company Secretary
Jing Yang
Assistant Accountant
Seung Jo Ahn
Assistant Accountant
Employees by Seniority
C-level
1employees
Senior
1employees
Non-managers
4employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of IMMUTEP LIMITED?
- Where is IMMUTEP LIMITED's headquarter?
- What IMMUTEP LIMITED's spending power?
- Does IMMUTEP LIMITED have a presence in the domain it operates in?